Vertex teams up with Feng Zhang startup on gene editing tech
January 03, 2019 at 10:33 AM EST
Zhang, a core member of the Broad Institute, played a leading role in developing the gene editing tool CRISPR/Cas9.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.